Related Experiment Video
Updated: Oct 18, 2025
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma
Marina Barcena-Varela1,2,3,4,5, Amaia Lujambio6,2,3,4,5,7
1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Abstract:
The study by Unfried and colleagues reports the intriguing discovery of a novel long noncoding RNA (lncRNA) with a critical role in the regulation of DNA damage response in hepatocellular carcinoma. Providing an exhaustive and detailed characterization of the complex network interactions within the double-stranded breaks in the DNA, the authors demonstrated that NIHCOLE serves as a scaffold and facilitator of nonhomologous end-joining machinery. This study greatly contributes to the growing evidence supporting the key roles of ncRNAs in health and disease. Although larger studies are needed to understand the potential of lncRNAs to improve the clinical management of patients with cancer, this study demonstrates that high expression of NIHCOLE may be associated with an impaired response to DNA damage-based therapies, in part through its role in preventing cell death.See related article by Unfried et al., p. 4910.
Insights
Researchers discovered a new long noncoding RNA (lncRNA), NIHCOLE, crucial for DNA repair in liver cancer. High NIHCOLE levels may hinder cancer therapies by preventing cell death.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cellular processes.
- DNA damage response (DDR) is critical for maintaining genomic stability and preventing cancer.
- Hepatocellular carcinoma (HCC) is a major global health concern with complex underlying mechanisms.
Purpose of the Study:
- To identify and characterize novel lncRNAs involved in the DNA damage response in hepatocellular carcinoma.
- To elucidate the functional role of the identified lncRNA, NIHCOLE, in DNA repair pathways.
- To investigate the potential clinical implications of NIHCOLE expression in cancer therapy response.
Main Methods:
- Comprehensive characterization of lncRNA expression and function in HCC models.
- Investigating the interaction of NIHCOLE with DNA repair machinery, specifically nonhomologous end-joining (NHEJ).
- Assessing the impact of NIHCOLE expression on cellular response to DNA damage and cell death.
Main Results:
- Discovery and characterization of a novel lncRNA, NIHCOLE, in hepatocellular carcinoma.
- NIHCOLE functions as a scaffold and facilitator for the nonhomologous end-joining DNA repair complex.
- High expression of NIHCOLE is associated with impaired response to DNA damage-based therapies, potentially by inhibiting apoptosis.
Conclusions:
- NIHCOLE plays a critical role in regulating the DNA damage response in HCC.
- The findings highlight the importance of lncRNAs in cancer pathogenesis and therapeutic resistance.
- Targeting NIHCOLE or understanding its role could offer new strategies for improving cancer treatment outcomes.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
01:20Types of RNA
RNA Performs Diverse...
02:15Experimental RNAi
02:37DNA Damage can Stall the Cell Cycle
02:37DNA Damage Can Stall the Cell Cycle
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...